First Time Loading...

NanoRepro AG
XETRA:NN6

Watchlist Manager
NanoRepro AG Logo
NanoRepro AG
XETRA:NN6
Watchlist
Price: 1.83 EUR -0.27% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

NN6 Price Targets Summary
NanoRepro AG

There are no price targets for NN6.
NN6 Lowest Forecast
Wall Street Target
Not Available
NN6 Average Forecast
Wall Street Target
Not Available
NN6 Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NanoRepro AG Competitors:
Price Targets
SIBN
SI-BONE Inc
88% Upside
DXR
Daxor Corp
146% Upside
TMDX
Transmedics Group Inc
16% Downside
FPH
Fisher & Paykel Healthcare Corporation Ltd
12% Downside
SIBN
SI-BONE Inc
88% Upside
DXR
Daxor Corp
146% Upside
TMDX
Transmedics Group Inc
16% Downside
FPH
Fisher & Paykel Healthcare Corporation Ltd
12% Downside
6669
Acotec Scientific Holdings Ltd
178% Upside
002432
Andon Health Co Ltd
56% Downside
78W
Modulight Oyj
124% Upside
S
688212
Shanghai Aohua Photoelectricity Endoscope Co Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
NanoRepro AG

For the last 8 years the compound annual growth rate for NanoRepro AG's revenue is 88%. The projected CAGR for the next 5 years is -61%.

88%
Past Growth
-61%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
NanoRepro AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
NanoRepro AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

See Also

Summary
NN6 intrinsic value, competitors valuation, and company profile.
DCF Valuation
NN6 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NN6 stock valuation using valuation multiples.
Wall Street Estimates
NN6 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NN6 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NN6's stock price target?
Not Available

NN6 doesn't have any price targets made by Wall Street professionals.

What is NanoRepro AG's Revenue forecast?
Projected CAGR
-61%

For the last 8 years the compound annual growth rate for NanoRepro AG's revenue is 88%. The projected CAGR for the next 5 years is -61%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.